annual cash & cash equivalents:
$289.20M+$85.50M(+41.97%)Summary
- As of today (June 2, 2025), IOSP annual cash & cash equivalents is $289.20 million, with the most recent change of +$85.50 million (+41.97%) on December 31, 2024.
- During the last 3 years, IOSP annual cash & cash equivalents has risen by +$147.40 million (+103.95%).
- IOSP annual cash & cash equivalents is now at all-time high.
Performance
IOSP Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$299.80M+$10.60M(+3.67%)Summary
- As of today (June 2, 2025), IOSP quarterly cash & cash equivalents is $299.80 million, with the most recent change of +$10.60 million (+3.67%) on March 31, 2025.
- Over the past year, IOSP quarterly cash & cash equivalents has increased by +$29.70 million (+11.00%).
- IOSP quarterly cash & cash equivalents is now -1.32% below its all-time high of $303.80 million, reached on September 30, 2024.
Performance
IOSP quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IOSP Cash and cash equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +42.0% | +11.0% |
3 y3 years | +104.0% | +183.9% |
5 y5 years | +282.0% | +340.2% |
IOSP Cash and cash equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +104.0% | -1.3% | +319.9% |
5 y | 5-year | at high | +282.0% | -1.3% | +415.1% |
alltime | all time | at high | +1980.6% | -1.3% | +2056.8% |
IOSP Cash and cash equivalents History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $299.80M(+3.7%) |
Dec 2024 | $289.20M(+42.0%) | $289.20M(-4.8%) |
Sep 2024 | - | $303.80M(+26.5%) |
Jun 2024 | - | $240.20M(-11.1%) |
Mar 2024 | - | $270.10M(+32.6%) |
Dec 2023 | $203.70M(+38.5%) | $203.70M(-1.7%) |
Sep 2023 | - | $207.20M(+24.9%) |
Jun 2023 | - | $165.90M(+12.5%) |
Mar 2023 | - | $147.50M(+0.3%) |
Dec 2022 | $147.10M(+3.7%) | $147.10M(+46.4%) |
Sep 2022 | - | $100.50M(+40.8%) |
Jun 2022 | - | $71.40M(-32.4%) |
Mar 2022 | - | $105.60M(-25.5%) |
Dec 2021 | $141.80M(+34.7%) | $141.80M(+59.0%) |
Sep 2021 | - | $89.20M(-5.5%) |
Jun 2021 | - | $94.40M(-19.3%) |
Mar 2021 | - | $117.00M(+11.1%) |
Dec 2020 | $105.30M(+39.1%) | $105.30M(+58.1%) |
Sep 2020 | - | $66.60M(+14.4%) |
Jun 2020 | - | $58.20M(-14.5%) |
Mar 2020 | - | $68.10M(-10.0%) |
Dec 2019 | $75.70M(-38.5%) | $75.70M(-31.4%) |
Sep 2019 | - | $110.30M(+4.0%) |
Jun 2019 | - | $106.10M(-14.1%) |
Mar 2019 | - | $123.50M(+0.3%) |
Dec 2018 | $123.10M(+36.5%) | $123.10M(+34.7%) |
Sep 2018 | - | $91.40M(+38.5%) |
Jun 2018 | - | $66.00M(-15.5%) |
Mar 2018 | - | $78.10M(-13.4%) |
Dec 2017 | $90.20M(-11.5%) | $90.20M(+37.7%) |
Sep 2017 | - | $65.50M(+34.2%) |
Jun 2017 | - | $48.80M(+7.5%) |
Mar 2017 | - | $45.40M(-55.4%) |
Dec 2016 | $101.90M(-25.6%) | $101.90M(-39.0%) |
Sep 2016 | - | $167.10M(+9.1%) |
Jun 2016 | - | $153.20M(+35.1%) |
Mar 2016 | - | $113.40M(-17.2%) |
Dec 2015 | $136.90M(+229.1%) | $136.90M(+7.2%) |
Sep 2015 | - | $127.70M(+98.6%) |
Jun 2015 | - | $64.30M(+38.3%) |
Mar 2015 | - | $46.50M(+11.8%) |
Dec 2014 | $41.60M(-48.1%) | $41.60M(-54.0%) |
Sep 2014 | - | $90.40M(-1.1%) |
Jun 2014 | - | $91.40M(+1.4%) |
Mar 2014 | - | $90.10M(+12.3%) |
Dec 2013 | $80.20M(+258.0%) | $80.20M(+48.8%) |
Sep 2013 | - | $53.90M(-1.5%) |
Jun 2013 | - | $54.70M(+26.6%) |
Mar 2013 | - | $43.20M(+92.9%) |
Dec 2012 | $22.40M(-70.6%) | $22.40M(-82.7%) |
Sep 2012 | - | $129.60M(+22.5%) |
Jun 2012 | - | $105.80M(+16.0%) |
Mar 2012 | - | $91.20M(+19.7%) |
Dec 2011 | $76.20M | $76.20M(-42.3%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2011 | - | $132.10M(+33.4%) |
Jun 2011 | - | $99.00M(+10.1%) |
Mar 2011 | - | $89.90M(-16.1%) |
Dec 2010 | $107.10M(+56.1%) | $107.10M(+8.4%) |
Sep 2010 | - | $98.80M(+34.1%) |
Jun 2010 | - | $73.70M(+14.8%) |
Mar 2010 | - | $64.20M(-6.4%) |
Dec 2009 | $68.60M(+393.5%) | $68.60M(+36.7%) |
Sep 2009 | - | $50.20M(+12.8%) |
Jun 2009 | - | $44.50M(+25.4%) |
Mar 2009 | - | $35.50M(+155.4%) |
Dec 2008 | $13.90M(-42.8%) | $13.90M(-8.6%) |
Sep 2008 | - | $15.20M(-7.3%) |
Jun 2008 | - | $16.40M(+16.3%) |
Mar 2008 | - | $14.10M(-42.0%) |
Dec 2007 | $24.30M(-76.2%) | $24.30M(-14.1%) |
Sep 2007 | - | $28.30M(-18.7%) |
Jun 2007 | - | $34.80M(+0.3%) |
Mar 2007 | - | $34.70M(-65.9%) |
Dec 2006 | $101.90M(+47.9%) | $101.90M(+10.9%) |
Sep 2006 | - | $91.90M(+39.7%) |
Jun 2006 | - | $65.80M(+10.2%) |
Mar 2006 | - | $59.70M(-13.4%) |
Dec 2005 | $68.90M(+106.9%) | $68.90M(+6.7%) |
Sep 2005 | - | $64.60M(+130.7%) |
Jun 2005 | - | $28.00M(-38.6%) |
Mar 2005 | - | $45.60M(+36.9%) |
Dec 2004 | $33.30M(-27.8%) | $33.30M(-4.3%) |
Sep 2004 | - | $34.80M(-55.6%) |
Jun 2004 | - | $78.30M(+15.3%) |
Mar 2004 | - | $67.90M(+47.3%) |
Dec 2003 | $46.10M(+72.7%) | $46.10M(+4.5%) |
Sep 2003 | - | $44.10M(+53.7%) |
Jun 2003 | - | $28.70M(-8.3%) |
Mar 2003 | - | $31.30M(+17.2%) |
Dec 2002 | $26.70M(-37.9%) | $26.70M(-13.9%) |
Sep 2002 | - | $31.00M(+14.8%) |
Jun 2002 | - | $27.00M(+6.3%) |
Mar 2002 | - | $25.40M(-40.9%) |
Dec 2001 | $43.00M(+14.1%) | $43.00M(-2.3%) |
Sep 2001 | - | $44.00M(+41.5%) |
Jun 2001 | - | $31.10M(-52.9%) |
Mar 2001 | - | $66.00M(+75.1%) |
Dec 2000 | $37.70M(+1.3%) | $37.70M(-8.9%) |
Sep 2000 | - | $41.40M(-27.4%) |
Jun 2000 | - | $57.00M(+32.6%) |
Mar 2000 | - | $43.00M(+15.6%) |
Dec 1999 | $37.20M(+40.4%) | $37.20M(+44.2%) |
Sep 1999 | - | $25.80M(+61.3%) |
Jun 1999 | - | $16.00M(-48.9%) |
Mar 1999 | - | $31.30M(+18.1%) |
Dec 1998 | $26.50M | $26.50M(-46.6%) |
Sep 1998 | - | $49.60M(+18.1%) |
Jun 1998 | - | $42.00M(+26.1%) |
Mar 1998 | - | $33.30M |
FAQ
- What is Innospec annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Innospec?
- What is Innospec annual cash & cash equivalents year-on-year change?
- What is Innospec quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Innospec?
- What is Innospec quarterly cash & cash equivalents year-on-year change?
What is Innospec annual cash & cash equivalents?
The current annual cash & cash equivalents of IOSP is $289.20M
What is the all time high annual cash & cash equivalents for Innospec?
Innospec all-time high annual cash & cash equivalents is $289.20M
What is Innospec annual cash & cash equivalents year-on-year change?
Over the past year, IOSP annual cash & cash equivalents has changed by +$85.50M (+41.97%)
What is Innospec quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of IOSP is $299.80M
What is the all time high quarterly cash & cash equivalents for Innospec?
Innospec all-time high quarterly cash & cash equivalents is $303.80M
What is Innospec quarterly cash & cash equivalents year-on-year change?
Over the past year, IOSP quarterly cash & cash equivalents has changed by +$29.70M (+11.00%)